Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

2.50
+0.17007.30%
Post-market: 2.520.0200+0.80%19:55 EDT
Volume:368.92K
Turnover:914.46K
Market Cap:204.15M
PE:-22.45
High:2.55
Open:2.35
Low:2.33
Close:2.33
Loading ...

I-Mab Regains Compliance With Nasdaq Minimum Bid Price Requirement

THOMSON REUTERS
·
12 Jun

Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
09 Jun

I-Mab Unveils Corporate Presentation Highlighting Advancements in Givastomig for Gastric Cancer and Strategic Growth Initiatives

Reuters
·
02 Jun

I-MAB Strengthens Board with New Appointment of Dr. Sean Cao

TIPRANKS
·
30 May

I-Mab initiated with a Buy at Lucid Capital

TIPRANKS
·
28 May

I-Mab to Present at Jefferies Global Healthcare Conference

GlobeNewswire
·
20 May

Analysts Offer Insights on Healthcare Companies: I-MAB (IMAB) and Durect (DRRX)

TIPRANKS
·
18 May

I-Mab reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
16 May

BRIEF-I-Mab Reports First Quarter 2025 Financial Results

Reuters
·
15 May

I-Mab Reported Q1 Net Loss Per ADS Of $(0.04), Cash Balance Of $168.6M

Benzinga
·
15 May

I-Mab Reports Strong Financial Position with $168.6M Cash and Investments, Interest Income Rises in Q1 2025

Reuters
·
15 May

Press Release: I-Mab Reports First Quarter 2025 Financial Results and Provides Business Update

Dow Jones
·
15 May

BRIEF-I-Mab Announces Givastomig Abstract Accepted For Oral Presentation At ESMO GI 2025

Reuters
·
30 Apr

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at Esmo Gi 2025

THOMSON REUTERS
·
30 Apr

I-Mab Announces Givastomig Abstract Accepted for Oral Presentation at ESMO GI 2025

GlobeNewswire
·
30 Apr

After Plunging -19.7% in 4 Weeks, Here's Why the Trend Might Reverse for IMab (IMAB)

Zacks
·
11 Apr

I-Mab Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
04 Apr

I-Mab expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
04 Apr

BRIEF-I-Mab Reports Full Year 2024 Financial Results

Reuters
·
04 Apr

I-MAB FY24 Adj EPADS $(0.27) Up From $(2.50) YoY

Benzinga
·
04 Apr